Tata 1mg/E-PHARMACY / HEALTHTECH / DIAGNOSTICSUpdated: 17 May 2026

Tata 1mg's Standalone Made ₹65 Cr Profit. The Group Lost ₹271 Cr.

Tata 1mg revenue, PAT, debt and cash flow, from the Standalone and consolidated audited financial statements FY2025, Tata 1mg Technologies Private Limited (operating brand: Tata 1mg).

+₹65 Cr
Standalone PAT (tripled YoY)
-₹271 Cr
Consolidated PAT (loss narrowed 13%)
₹375 → ₹2,353 Cr
Standalone vs consolidated revenue
+₹290 Cr
Increase in group borrowings
UnpopularVoice Editorial8 min read  ·  Financial deep dive
What the numbers actually say19 metrics
MetricReported(Narrative)Economic Reality
Standalone Revenue (FY25)₹375.49 Crup 36% from ₹275.46 Cr; intercompany platform fees
Standalone PAT (FY25)+₹65.37 Crup 196% from +₹22.09 Cr; profitable both years
Standalone Net Worth+₹1,338.74 Crinvestment in subsidiaries ₹1,225.84 Cr at cost
Standalone Inventories₹0parent does not hold inventory
Standalone Borrowings₹1.11 CrDeutsche Bank OD; almost zero
Consolidated Revenue (FY25)₹2,353.27 Crup 19.6% from ₹1,967.75 Cr; external customer revenue
Consolidated PAT (FY25)-₹271.19 Crfrom -₹312.99 Cr; loss narrowed 13%
Consolidated PAT attributable to Parent-₹280.81 Crnon-controlling interest +₹9.62 Cr (a partly-owned sub had profit)
Consolidated OCF (FY25)-₹201.63 Crfrom -₹270.68 Cr; improved ₹69 Cr
Consolidated Inventories₹176.85 Crfrom ₹127.10 Cr; operating subsidiaries hold pharmacy stock
Consolidated Borrowings (current)₹654.76 Crfrom ₹364.98 Cr; +₹290 Cr in FY25
Consolidated Finance Costs₹50.12 Crfrom ₹29.93 Cr; +67% YoY
Consolidated PPE Additions (FY25)₹122.89 Crfrom ₹9.86 Cr; 12x growth
Consolidated Net Worth-₹351.70 Crfrom -₹93.66 Cr; accumulated group losses
Consolidated Total Assets₹755.70 Crfrom ₹582.12 Cr
Parent (Holding) CompanyTata Digital Private Limited100% holder; pre-acquisition OCRPS converted to equity in Jul 2023
Standalone Employee Benefits₹132.47 Cr+7% YoY
Consolidated Employee Benefits₹412.19 Cr+10% YoY
Standalone Investment in Subsidiaries₹1,225.84 Crunquoted, carried at cost

The 30-Second Summary

Tata 1mg's standalone audit reports a profit of ₹65 Cr. The consolidated audit reports a loss of ₹271 Cr. Both are from the same filing. They describe different things.

  • Standalone PAT +₹65.37 Cr. Up 196% from +₹22.09 Cr. The standalone is the parent entity's own P&L: ₹375 Cr of revenue from intercompany platform fees, IP, and services charged to operating subsidiaries.

  • Consolidated PAT -₹271.19 Cr. Loss narrowed 13% from -₹312.99 Cr. The consolidated combines the parent and all subsidiaries with intercompany transactions eliminated, producing the group's external revenue of ₹2,353 Cr.

  • Consolidated revenue ₹2,353 Cr, up 19.6%. The operating business at the group level is growing; the standalone revenue scales because the parent is charging more to subsidiaries as the group grows.

  • Borrowings up ₹290 Cr at group level. Funded the ₹202 Cr consolidated operating cash burn plus a ₹123 Cr property build-out. Finance costs rose 67%.

  • Consolidated net worth -₹352 Cr. Reflects cumulative group losses against Tata Digital's equity contribution; structurally an accounting representation of parent-funded loss accumulation, not a distress signal.

What Each Read Captures

  • Legal entity: Tata 1mg Technologies Pvt Ltd, Delhi-incorporated 2015, registered office in Okhla Industrial Area.
  • Brand: Tata 1mg, an online pharmacy, diagnostics, and teleconsultation platform.
  • Holding structure: 100% owned by Tata Digital Private Limited. Pre-acquisition OCRPS held by Tata Digital converted to equity in July 2023.
  • Operating structure: a multi-entity group. The parent (Tata 1mg Technologies) charges intercompany platform fees, IP, and services to operating subsidiaries that run the pharmacy and diagnostics business.
  • What the standalone captures: parent-level revenue (intercompany), parent-level employee and corporate costs, investments in subsidiaries at cost, group-level intangibles held at parent. No inventory, no end-customer revenue, minimal borrowings.
  • What the standalone does not capture: external customer revenue, pharmacy inventory, the bulk of working capital, the operating subsidiaries' borrowings, the actual group operating result.
  • What the consolidated captures: all of the above, with intercompany transactions eliminated. The group's external revenue, total inventory, total borrowings, and combined operating result.

The two reads are not contradictory. They are answers to different questions. The standalone answers: how does the parent entity itself perform on its own books? The consolidated answers: how does the group as a whole perform against external customers?

The core insight

One filing, two audits. The standalone is the parent's books. The consolidated is the business.

The Two Reads of FY25

Revenue

Standalone (parent intercompany)

₹375.49 Cr

Consolidated (group external)

₹2,353.27 Cr

Profit After Tax (FY25)

Standalone

+₹65.37 Cr

Consolidated

-₹271.19 Cr

Net Worth (March 31, 2025)

Standalone

+₹1,338.74 Cr

Consolidated

-₹351.70 Cr

Borrowings (March 31, 2025)

Standalone

₹1.11 Cr

Consolidated

₹654.76 Cr

Inventories (March 31, 2025)

Standalone

₹0 Cr

Consolidated

₹176.85 Cr

Five line items, two readings each, four major divergences. The pattern is not random: each gap describes a part of the business that does not sit at the parent level.

Where the gap comes from

The parent layer collects intercompany fees; the group layer owns the operating business

The standalone revenue of ₹375.49 Cr is what Tata 1mg Technologies Pvt Ltd (the parent legal entity) earns from its own activities. The filing does not fully disaggregate the composition of this revenue, but for a parent in a multi-entity Indian holding structure the typical mix is: intercompany platform fees, IP and brand royalty income, corporate services, and any direct revenue the parent itself contracts.

In consolidation, intercompany flows are eliminated. What remains is the group's external revenue, ₹2,353.27 Cr, sold to end customers buying medicines, diagnostic tests, and consultations. The standalone ₹375 Cr does not appear in the consolidated revenue line; it appears (in part) as a reduction in subsidiary expenses upon elimination.

The standalone PAT of +₹65.37 Cr is the parent's own profit, computed on its intercompany revenue minus its own employee, finance, depreciation, and other costs. The consolidated PAT of -₹271.19 Cr is the group's combined operating result; the parent's standalone profit is included in this figure, but the subsidiaries' larger combined loss exceeds it. The arithmetic difference between the two PAT figures is approximately ₹336 Cr, which represents the consolidated impact of the subsidiaries' net loss plus consolidation adjustments.

The standalone investment line carries ₹1,225.84 Cr of unquoted investments in subsidiaries at cost. This is the parent's equity stake. On the consolidated balance sheet, this investment line is eliminated and replaced by the subsidiaries' actual assets, liabilities, and accumulated losses.

What Improved in the Operating Group

Consolidated operating lines, FY2024 → FY2025The group's external-customer view

Revenue

₹1,968 → ₹2,353 Cr

+19.6% YoY

Purchases of Stock-in-Trade

₹1,295 → ₹1,539 Cr

+18.8%; tracks revenue

Employee Benefits

₹374 → ₹412 Cr

+10.3%; below revenue growth

Finance Costs

₹30 → ₹50 Cr

+67%; debt service rising

Loss Before Tax

-₹312 → -₹283 Cr

narrowed 9%

Profit After Tax (loss)

-₹313 → -₹271 Cr

narrowed 13% (incl. tax credit)

Operating Cash Flow

-₹271 → -₹202 Cr

+₹69 Cr improvement

At the consolidated level FY25 shows: revenue +19.6%, loss narrowed 13%, operating cash burn improved 26%. Three lines on the same audit work in the opposite direction:

  • Borrowings expanded ₹290 Cr. Almost entirely funded the gap between operating cash burn and capex. Group borrowings grew from ₹365 Cr to ₹655 Cr; finance costs rose 67% accordingly.

  • Property and equipment additions ₹123 Cr. Up 12x from ₹10 Cr in FY24. The filing records the magnitude but does not disaggregate the composition of the additions or their intended deployment.

  • Trade receivables and inventories both grew faster than revenue. Receivables expanded from ₹117 Cr to ₹175 Cr (+49%) and inventories from ₹127 Cr to ₹177 Cr (+39%). Both growth rates exceed the 19.6% revenue growth, which absorbed working capital and explains part of the OCF drag against the loss-narrowing.

Capital Structure: How Tata Digital's Investment Sits Across the Two Books

Capital structure across standalone and consolidatedThe same Tata Digital equity, two accounting views

Equity Share Capital (Standalone & Consolidated)

₹0.10 Cr

face value; identical at both levels

Standalone Other Equity

+₹1,338.64 Cr

premium + reserves + parent's accumulated P&L

Consolidated Other Equity

-₹351.80 Cr

after netting subsidiaries' accumulated losses

Standalone Investment in Subsidiaries (at cost)

₹1,225.84 Cr

eliminated in consolidation

Standalone PAT (cumulative profitable)

Profitable both years

₹22 Cr (FY24) + ₹65 Cr (FY25)

Consolidated PAT (cumulative loss-making)

Loss both years

-₹313 Cr (FY24) + -₹271 Cr (FY25) = -₹584 Cr

The two-level capital view

The parent layer holds the investment; the group layer absorbs the losses

At March 31, 2025, the standalone balance sheet of Tata 1mg Technologies Pvt Ltd shows positive net worth of ₹1,338.74 Cr. The bulk of this is the parent's investment in subsidiaries, recorded at cost at ₹1,225.84 Cr. The parent has not impaired this investment despite the consolidated group operating at a loss.

In consolidation, this investment line is eliminated and replaced by the subsidiaries' actual assets and liabilities. After eliminating intercompany transactions and netting all subsidiary accumulated losses, the consolidated equity is -₹351.70 Cr. The arithmetic gap between the two net worth figures, approximately ₹1,690 Cr, reflects the cumulative gap between the parent's investment carrying cost and the underlying group equity, including all the operating losses absorbed at the subsidiary level.

The structural read: the consolidated negative net worth is not a distress signal in the conventional sense. It is the accounting representation of accumulated group losses against Tata Digital's equity contribution to the entity. Continued operations depend on parent funding cadence (further equity infusion or borrowings backed by parent comfort), not on standalone or consolidated cash generation reaching positive territory in this year's filing.

The pre-acquisition OCRPS structure (117,197 instruments held by Tata Digital, converted to equity in July 2023) is no longer outstanding. The current capital structure is ordinary equity held by Tata Digital plus group-level borrowings that fund working capital and capex.

What FY25 records at the parent layer

Standalone revenue ₹375 Cr (+36%). Standalone PAT ₹65 Cr (tripled). Zero meaningful debt. Net worth ₹1,339 Cr. ₹10 Cr cash. The parent's intercompany earnings are larger than a year ago.

What FY25 records at the group level

Consolidated PAT -₹271 Cr. Net worth -₹352 Cr. Borrowings up ₹290 Cr to ₹655 Cr. Finance costs +67%. Operating cash burn -₹202 Cr, funded during the year by ₹220 Cr of financing inflow and matched against ₹123 Cr of property additions.

One filing, two audits. The standalone shows a profitable parent. The consolidated shows a loss-making group. Both are accurate. The first counts intercompany; the second counts the customer.

UnpopularVoice editorial read
Key Takeaways6 points
1TATA 1MG TECHNOLOGIES PRIVATE LIMITED (CIN U74140DL2015PTC279229), Delhi-incorporated 2015, operates the Tata 1mg brand of online pharmacy, diagnostics, and consultations. 100% owned by Tata Digital Private Limited (the parent acquired the entity in 2021-22). Pre-acquisition Optionally Convertible Redeemable Preference Shares (OCRPS) were converted to equity in July 2023, bringing the group fully into Tata Digital's equity structure.
2FY2025 standalone revenue ₹375.49 Cr (FY24: ₹275.46 Cr, +36%). Standalone PAT +₹65.37 Cr (FY24: +₹22.09 Cr, +196%). The standalone P&L represents the parent entity's intercompany platform fees, IP/royalty income, and corporate services charged to operating subsidiaries. The standalone holds ₹1,225.84 Cr of unquoted investments in those subsidiaries and zero inventory.
3FY2025 consolidated revenue ₹2,353.27 Cr (FY24: ₹1,967.75 Cr, +19.6%). Consolidated PAT -₹271.19 Cr (FY24: -₹312.99 Cr, loss narrowed 13%). Consolidated inventories ₹176.85 Cr. Consolidated borrowings ₹654.76 Cr (FY24: ₹364.98 Cr, +₹290 Cr). Property additions ₹122.89 Cr (FY24: ₹9.86 Cr, +12x). The consolidated reflects the actual pharmacy and diagnostics business with end-customer revenue.
4Both audits are from the same standalone-and-consolidated filing under Ind AS. The standalone profit and the consolidated loss describe different things: the parent's intercompany earnings versus the group's operating result against external customers.
5Consolidated net worth -₹351.70 Cr (FY24: -₹93.66 Cr). The negative position reflects accumulated group losses since inception against the equity infusion from Tata Digital. Standalone net worth is +₹1,338.74 Cr because the parent's investment in subsidiaries (₹1,225.84 Cr) is carried at cost on the standalone books and is not netted against the subsidiaries' accumulated losses. Borrowings at consolidated level are largely unsecured working-capital lines (Deutsche Bank OD ₹11 Cr on standalone; the bulk sits in subsidiaries).
6Operating signals: consolidated OCF improved to -₹201.63 Cr (FY24: -₹270.68 Cr). The improvement is real but is matched by ₹220.58 Cr of financing cash inflow, primarily increased borrowings, and ₹122.89 Cr of property additions. Finance costs at group level rose 67% to ₹50.12 Cr.